NCT03721588

Brief Summary

In the presence of attention deficit hyperactivity disorder (ADHD) together with additional psychiatric diseases, the treatment process and prognosis of both ADHD and psychiatric comorbidity are adversely affected. The aim of this study is to compare the characteristics concerning the suicidal behavior of the patients with major depressive disorder (MDD) who have (ADHD+) or do not have (ADHD-) adult ADHD comorbidity and their responses to depression treatment. 96 inpatients were included in the study. Socio-demographic data form, Hamilton Depression Scale (HDRS), Wender Utah Rating Scale (WURS), Adult ADD/ADHD DSM IV- Based Diagnostic Screening and Rating Scale (A-ADHD), Personal and Social Performance Scale (PSP) were applied to the cases. In the study, depression starts at an early age in individuals with comorbid ADHD and the depression treatment progress changes negatively. This group of patients is at greater risk in terms of suicidal behavior. For these reasons, clinicians should be careful during ADHD and depression management in adults.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 12, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 26, 2018

Completed
Last Updated

October 30, 2018

Status Verified

October 1, 2018

Enrollment Period

1.8 years

First QC Date

October 12, 2018

Last Update Submit

October 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • depressive inpatients with comorbid ADHD (n=48) and without comorbid ADHD (n=48) were compared according to the suicidal behavior, the onset age of depression, the response to the treatment, and psychosocial functioning.

    Clinical interviews, psychometric scales such as, Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Hamilton Depression Rating Scale (HDRS), Adult ADD/ADHD DSM IV- Based Diagnostic Screening and Rating Scale (A-ADHDS), Wender Utah Rating Scale (WURS), Personal and Social Performance Scale (PSP) were applied. 96 inpatients were included in the study. In our study, depression starts at an early age in individuals with comorbid ADHD and the depression treatment progress changes negatively. This group of patients is at greater risk in terms of suicidal behavior.

    2 years

Study Arms (2)

Major depressive disorder

MDD; patients with diagnosis of major depressive disorder, Clinical interviews, psychometric scales were applied.

Other: Clinical interviews, psychometric scales were applied.

MDD and ADHD

MDD; major depressive disorder ADHD; attention deficit hyperactivity disorder, Clinical interviews, psychometric scales were applied.

Other: Clinical interviews, psychometric scales were applied.

Interventions

MDD and ADHDMajor depressive disorder

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

inpatiets with diagnosis of major depressive disorder

You may qualify if:

  • Complying with DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth) criteria for major depression
  • Hamilton Depression Scale (HDRS) being over 16 points during hospitalization

You may not qualify if:

  • Mental retardation
  • Psychotic disorder
  • Alcohol or substance addiction
  • History of head trauma
  • Being under psychostimulant treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Duran S, Fistikci N, Keyvan A, Bilici M, Caliskan M. [ADHD in adult psychiatric outpatients: prevalence and comorbidity]. Turk Psikiyatri Derg. 2014 Summer;25(2):84-93. Turkish.

  • Agosti V, Chen Y, Levin FR. Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts? J Affect Disord. 2011 Oct;133(3):595-9. doi: 10.1016/j.jad.2011.05.008. Epub 2011 Jun 11.

  • Tamam L, Demirkol ME. Adult attention deficit/hyperactivity disorder and mood disorders. Turkiye Klin J Psychiatry-Special Top 2012;5:48-3.

    RESULT
  • Ekinci S, Öncü B, Canat S. Adult attention deficit hyperactivity disorder: comorbidity and functioning. Anadolu Psikiyatr Derg 2011;12:185-1.

    RESULT

MeSH Terms

Conditions

Depressive Disorder, MajorAttention Deficit Disorder with HyperactivitySuicide

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersAttention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Esin Erdogan, MD

    Bozyaka Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Psychiatry Department, MD

Study Record Dates

First Submitted

October 12, 2018

First Posted

October 26, 2018

Study Start

September 1, 2015

Primary Completion

June 1, 2017

Study Completion

September 1, 2017

Last Updated

October 30, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share